BXBei Xue

Bei Xue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bei Xue has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Dan-Dan Zhao

    Key Laboratory of Molecular Biology of Heilongjiang Province, College of Life Science, Heilongjiang University, Harbin 150080, China

    1 shared publication
  • Shuai Jiang

    Sino-Russian Joint Laboratory of Bioactive Substance, College of Life Science, Heilongjiang University, Harbin 150080, China

    1 shared publication
  • Xiufeng Yan

    College of Life and Environmental Science, Wenzhou University, Wenzhou 325035, China

    1 shared publication
  • Yan-Long Zhang

    Engineering Research Center of Agricultural Microbiology Technology, Ministry of Education & Heilongjiang Provincial Key Laboratory of Ecological Restoration and Resource Utilization for Cold Region & Key Laboratory of Microbiology, College of Heilongjiang Province & School of Life Sciences, Heilongjiang University, Harbin, China

    1 shared publication
  • Zhendong Liu

    Food Science College, Tibet Agriculture & Animal Husbandry University, Nyingchi 860000, China

    1 shared publication

Latest Publications

  • Open Access

    Anticancer Phenolics from Dryopteris fragrans (L.) Schott

    by Zhen-Dong Liu, Dan-Dan Zhao, Shuai Jiang, Bei Xue, Yan-Long Zhang, Xiu-Feng Yan

    Cancer is one of the most major diseases that threatens human health and life. The aim of this work was to obtain novel anticancer molecules from D. fragrans, a kind of medicinal plant. The structure of the new compound was identified using spectroscopic data (1H-NMR, 13C-NMR and two dimensions NMR). Its anticancer properties were evaluated using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay against four human cells including lung cancer cells (A549), breast cancer cells (MCF-7), gastric cancer cells (SGC7901) and noncancerous human umbilical vein endothelial cells (HUVEC). A new phenylpropanoid—(E)-caffeic acid-9-O-β-d-xylpyranosyl-(1→2)-β-d-glucopyranosyl ester (1), with seven known compounds (2–8)—was isolated. The IC50 value of compound 1 against MCF-7 cells was 2.65 ± 0.14 µM, and the IC50 values of compound 8 against three cancer cells were below 20 µM.